Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119186) titled 'Research on Targeted B-Cell Activation Therapy for IgA Nephropathy' on Feb. 24.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China

Condition: IgA Nephropathy

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-01-25

Target Sample Size: The Telitacicept Cohort:10;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=276416

Published by HT Digital Content Services with permission from Health D...